Reimbursement Scheme Kesimpta®
The health insurer does not fully reimburse Kesimpta® injvlst 50mg/ml pen 0,4ml. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the Personal Contribution to the patient.
The Personal Contribution for Kesimpta® injvlst 50mg/ml pen 0,4ml that is demonstrably charged to the patient by the health insurer will be fully reimbursed from October 1 2023 up to a maximum of € 250 per patient per year.
Who can submit a claim
Only patients or their carer can claim the Personal Contribution for Kesimpta® injvlst 50mg/ml pen 0,4ml online or by post. Online will be the fastest option. Pharmacists cannot claim this medicine on behalf of the patient.